Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02923960 · ClinicalTrials.gov registry record · NA
Effect of Nutritional Products in Subjects With Type 2 Diabetes
A NA study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT02923960: Completed NA study, sponsored by Abbott Nutrition.
NCT02923960 is a NA study that has completed, run by Abbott Nutrition. The registered enrollment target is 43 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02923960, a NA study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
This is a randomized, double blinded, multi treatment, crossover study intended to compare the glycemic and insulinemic response after consuming liquid nutritional products in people with type 2 diabetes.
Interventions
- OTHER Standard ONS
- OTHER Diabetes specific ONS 1
- OTHER Diabetes specific ONS 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2016-10 |
| Est. Completion | 2017-01 |
| Phase | NA |
What the finished NCT02923960 record still lists
NCT02923960 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Standard ONS is the first listed.
NCT02923960 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02923960 about?
NCT02923960 is a clinical study titled "Effect of Nutritional Products in Subjects With Type 2 Diabetes". This is a randomized, double blinded, multi treatment, crossover study intended to compare the glycemic and insulinemic response after consuming liquid nutritional products in people with type 2 diabetes.
What is the current status of trial NCT02923960?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2016-10. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02923960?
The interventions under investigation include: Standard ONS (OTHER), Diabetes specific ONS 1 (OTHER), Diabetes specific ONS 2 (OTHER).
Who is sponsoring clinical trial NCT02923960?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02923960's enrollment target sits among peer trials
43 1435th of 2000 higher than 565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia